Singapore medical devices manufacturer, Biosensors International Group Ltd , is spending around S$82.2 million ($65.60 million)to develop a new manufacturing center and research and development centre in Singapore. The company manufactures medical devices used in interventional cardiology, namely drug-eluting stents (DES), used to treat blocked arteries, and critical care procedures. "In addition to the manufacturing of DES and other medical devices, the new facility will also be used to develop new high-technology, value-added medical devices, and is expected to be completed within three years," Biosensors said in a statement on Friday.
